Curcumin-loaded graphene oxide flakes as an effective antibacterial system against methicillin-resistant...

Area of Science:

• Nanomedicine
• Biomaterials
• Infectious Diseases

Background:

• Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant global health threat, causing severe hospital infections.
• Curcumin, derived from turmeric, exhibits antimicrobial properties against MRSA but is limited by poor solubility and cytotoxicity at effective doses.
• Developing novel therapeutic strategies is crucial to combat antibiotic-resistant bacterial infections.

Purpose of the Study:

• To develop and evaluate a novel composite nanoparticle, GOCU, for enhanced MRSA treatment.
• To assess the efficacy and safety profile of GOCU against MRSA infections.
• To investigate the potential of graphene oxide as a carrier for curcumin.

Main Methods:

• Fabrication of a curcumin (CU) and graphene oxide (GO) composite nanoparticle (GOCU).
• Evaluation of GOCU's efficacy against MRSA in vitro at low concentrations.
• Assessment of GOCU's cytotoxicity on fibroblast cells and hemolytic activity on red blood cells.

Main Results:

• GOCU demonstrated significant efficacy against MRSA at concentrations below 2 µg ml⁻¹.
• Graphene oxide effectively stabilized curcumin in an aqueous environment.
• GOCU exhibited low toxicity to fibroblast cells and did not cause significant red blood cell hemolysis.

Conclusions:

• GOCU is a promising nanomaterial for combating antibiotic-resistant MRSA infections.
• The composite nanoparticle overcomes the limitations of curcumin, offering a potentially safer and more effective treatment.
• Graphene oxide's inherent antibacterial properties and drug-loading capacity make it a valuable component in antimicrobial nanomedicine.